Private Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3M | Sell |
53,848
-2,199
| -4% | -$57.5K | 0.1% | 220 |
|
|
2026
Q1 | $1.57M | Sell |
56,047
-16,479
| -23% | -$439K | 0.14% | 156 |
|
|
2025
Q4 | $1.81M | Buy |
72,526
+8,978
| +14% | +$226K | 0.16% | 135 |
|
|
2025
Q3 | $1.62M | Sell |
63,548
-3,022
| -5% | -$74.6K | 0.14% | 152 |
|
|
2025
Q2 | $1.61M | Sell |
66,570
-1,988
| -3% | -$46.4K | 0.15% | 145 |
|
|
2025
Q1 | $1.74M | Buy |
68,558
+7,994
| +13% | +$209K | 0.18% | 132 |
|
|
2024
Q4 | $1.61M | Sell |
60,564
-15,641
| -21% | -$424K | 0.17% | 133 |
|
|
2024
Q3 | $2.21M | Buy |
76,205
+1,324
| +2% | +$38.6K | 0.22% | 96 |
|
|
2024
Q2 | $2.1M | Buy |
74,881
+4,731
| +7% | +$130K | 0.23% | 91 |
|
|
2024
Q1 | $1.95M | Sell |
70,150
-2,022
| -3% | -$56.1K | 0.21% | 100 |
|
|
2023
Q4 | $2.08M | Sell |
72,172
-14,837
| -17% | -$449K | 0.24% | 88 |
|
|
2023
Q3 | $2.89M | Sell |
87,009
-15,238
| -15% | -$539K | 0.38% | 47 |
|
|
2023
Q2 | $3.75M | Buy |
102,247
+3,205
| +3% | +$125K | 0.47% | 34 |
|
|
2023
Q1 | $4.04M | Sell |
99,042
-749
| -0.8% | -$32.4K | 0.55% | 30 |
|
|
2022
Q4 | $5.11M | Buy |
99,791
+4,812
| +5% | +$231K | 0.76% | 21 |
|
|
2022
Q3 | $4.16M | Buy |
94,979
+9,293
| +11% | +$452K | 0.68% | 24 |
|
|
2022
Q2 | $4.49M | Sell |
85,686
-21,240
| -20% | -$1.08M | 0.7% | 22 |
|
|
2022
Q1 | $5.54M | Sell |
106,926
-1,076
| -1% | -$55.8K | 0.86% | 21 |
|
|
2021
Q4 | $6.38M | Buy |
108,002
+2,148
| +2% | +$106K | 0.88% | 20 |
|
|
2021
Q3 | $4.55M | Buy |
105,854
+10,376
| +11% | +$460K | 0.66% | 31 |
|
|
2021
Q2 | $3.74M | Buy |
95,478
+3,538
| +4% | +$138K | 0.57% | 39 |
|
|
2021
Q1 | $3.33M | Sell |
91,940
-14,523
| -14% | -$516K | 0.54% | 45 |
|
|
2020
Q4 | $3.92M | Buy |
106,463
+8,456
| +9% | +$310K | 0.66% | 31 |
|
|
2020
Q3 | $3.41M | Sell |
98,007
-1,314
| -1% | -$46.1K | 0.66% | 33 |
|
|
2020
Q2 | $3.25M | Sell |
99,321
-12,606
| -11% | -$428K | 0.68% | 33 |
|
|
2020
Q1 | $3.47M | Sell |
111,927
-26,385
| -19% | -$899K | 0.9% | 20 |
|
|
2019
Q4 | $5.14M | Sell |
138,312
-34,953
| -20% | -$1.24M | 0.95% | 16 |
|
|
2019
Q3 | $5.91M | Buy |
173,265
+2,265
| +1% | +$82.4K | 1.16% | 12 |
|
|
2019
Q2 | $7.03M | Sell |
171,000
-322
| -0.2% | -$12.8K | 1.42% | 10 |
|
|
2019
Q1 | $6.9M | Buy |
171,322
+36,894
| +27% | +$1.48M | 1.44% | 10 |
|
|
2018
Q4 | $5.57M | Buy |
134,428
+95
| +0.1% | +$3.94K | 1.32% | 11 |
|
|
2018
Q3 | $5.62M | Sell |
134,333
-1,238
| -0.9% | -$47.7K | 1.15% | 13 |
|
|
2018
Q2 | $4.67M | Sell |
135,571
-1,919
| -1% | -$65.6K | 1.01% | 18 |
|
|
2018
Q1 | $4.63M | Sell |
137,490
-6,247
| -4% | -$215K | 1.01% | 17 |
|
|
2017
Q4 | $4.94M | Sell |
143,737
-96
| -0.1% | -$3.27K | 1.05% | 15 |
|
|
2017
Q3 | $4.87M | Sell |
143,833
-7,310
| -5% | -$235K | 1.06% | 15 |
|
|
2017
Q2 | $4.82M | Buy |
151,143
+16,782
| +12% | +$529K | 1.05% | 16 |
|
|
2017
Q1 | $4.36M | Buy |
134,361
+5,519
| +4% | +$174K | 1.01% | 18 |
|
|
2016
Q4 | $3.97M | Buy |
128,842
+3,578
| +3% | +$109K | 0.95% | 22 |
|
|
2016
Q3 | $4.03M | Buy |
125,264
+2,432
| +2% | +$81.3K | 0.98% | 21 |
|
|
2016
Q2 | $4.1M | Buy |
122,832
+1,668
| +1% | +$53.2K | 1.07% | 20 |
|
|
2016
Q1 | $3.41M | Buy |
121,164
+2,926
| +2% | +$83.6K | 0.92% | 24 |
|
|
2015
Q4 | $3.62M | Sell |
118,238
-1,513
| -1% | -$47.6K | 1.03% | 20 |
|
|
2015
Q3 | $3.57M | Sell |
119,751
-1,044
| -0.9% | -$33.5K | 1.07% | 20 |
|
|
2015
Q2 | $3.84M | Sell |
120,795
-1,011
| -0.8% | -$33K | 1.1% | 17 |
|
|
2015
Q1 | $4.02M | Buy |
121,806
+9,681
| +9% | +$308K | 1.15% | 16 |
|
|
2014
Q4 | $3.31M | Buy |
112,125
+23,769
| +27% | +$682K | 1.05% | 16 |
|
|
2014
Q3 | $2.48M | Sell |
88,356
-7,731
| -8% | -$217K | 0.84% | 18 |
|
|
2014
Q2 | $2.71M | Buy |
96,087
+1,845
| +2% | +$52.6K | 0.88% | 16 |
|
|
2014
Q1 | $2.87M | Buy |
94,242
+525
| +0.6% | +$15.7K | 1.08% | 15 |
|
|
2013
Q4 | $2.72M | Buy |
93,717
+339
| +0.4% | +$9.87K | 1.1% | 16 |
|
|
2013
Q3 | $2.54M | Buy |
93,378
+4,898
| +6% | +$133K | 1.15% | 13 |
|
|
2013
Q2 | $2.35M | Buy |
+88,480
| New | +$2.44M | 1.08% | 15 |
|
Other funds holding PFE
Private Trust Company's PFE Position: Q2 2026 in Review
Private Trust Company reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $57.5K and leaving 53,848 shares worth $1.3M. The position accounts for 0.1% of the portfolio, ranked #220.
Private Trust Company first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.03M in Q2 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Private Trust Company held 53,848 shares of Pfizer worth $1.3M as of Q2 2026.
- Private Trust Company sold 2,199 Pfizer shares in Q2 2026, an estimated $57.5K.
- Pfizer made up 0.1% of Private Trust Company's portfolio in Q2 2026, its #220 holding.
- Private Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Private Trust Company's Pfizer position peaked at $7.03M in Q2 2019.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.